The move would revoke abortion access for vets and eligible family members expanded in 2022 under the Biden administration. The expansion included states that ban abortion.

HealthDay News — Among US adolescents, current medical use of prescription stimulants for attention-deficit/hyperactivity disorder (ADHD) increased between 2005 and 2023, while nonmedical use ...

HealthDay News — Just under half of patients receiving an abnormal blood-based colorectal cancer screening test result receive a follow-up colonoscopy (FU-CY) within 6 months, according to a study ...

HealthDay News — Having a supratherapeutic international normalized ratio (INR) while taking warfarin does not significantly increase the risk for brain bleeding after blunt head trauma in older ...

Most life-years saved were among people aged 60 years or older; estimates are more conservative than those that focused on the first year of vaccination ...

The gender pay gap for US physicians hit 26% in 2024, which was an increase from the 23% pay gap observed in 2023, according to Doximity’s Physician Compensation Report 2025.

“We saw that critical-care management of brain swelling, along with immune modulating therapies such as plasma exchange and intravenous immunoglobin, appeared helpful for patients who recovered,” ...

The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for lisocabtagene maraleucel (liso-cel) for adults with relapsed or ...

HealthDay News Cannabis use disorder (CUD) is associated with an increased risk for oral cancer, according to a study published in the September issue of Preventive Medicine Reports.

In 2013, the Obama administration replaced the test with the Presidential Youth Fitness Program, which focused less on athletic skill and more on individual health.

Popular freeze-dried fruit snacks sold at Sam’s Club are being recalled because of possible listeria contamination.

The Food and Drug Administration (FDA) has issued another Complete Response Letter (CRL) to Regeneron (CRL) for the Biologics License Application (BLA) for odronextamab in relapsed/refractory ...